Author | Joyce F. Liu, MD, MPH | OncLive

Author | Joyce F. Liu, MD, MPH

Articles

Dr. Liu on Phase 2 Study Results of Adavosertib in Recurrent Uterine Serous Carcinoma

May 30, 2020

Video

Joyce F. Liu, MD, MPH, discusses findings from a phase 2 study with the Wee1 inhibitor adavosertib in patients with recurrent uterine serous carcinoma.

Dr. Liu on PARP Inhibitors in Recurrent Ovarian Cancer

April 16, 2019

Video

Joyce F. Liu, MD, MPH, assistant professor of medicine, Harvard Medical School, and director of clinical research for gynecologic oncology at Dana-Farber Cancer Institute, discusses the use of PARP inhibitors in patients with recurrent ovarian cancer.

Dr. Liu on the Use of Bevacizumab in Newly Diagnosed Advanced Ovarian Cancer

January 08, 2019

Video

Joyce F. Liu, MD, MPH, assistant professor of medicine and director of clinical research for gynecologic oncology at Dana-Farber Cancer Institute, discusses the use of bevacizumab (Avastin) in the treatment of patients with newly diagnosed advanced ovarian cancer.

x